Caveolin-2 in association with nuclear lamina controls adipocyte hypertrophy

FASEB J. 2023 Feb;37(2):e22745. doi: 10.1096/fj.202201028RR.

Abstract

Here, we identify that Caveolin-2 (Cav-2), an integral membrane protein, controls adipocyte hypertrophy in association with nuclear lamina. In the hypertrophy stage of adipogenesis, pY19-Cav-2 association with lamin A/C facilitated the disengagement of CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ) from lamin A/C and repressed Cav-2 promoter at the nuclear periphery for epigenetic activation of Cav-2, and thereby promoted C/EBPα and PPARγ-induced adipocyte hypertrophy. Stable expression of Cav-2 was required and retained by phosphorylation, deubiquitination, and association with lamin A/C for the adipocyte hypertrophy. However, obese adipocytes exhibited augmented Cav-2 stability resulting from the up-regulation of lamin A/C over lamin B1, protein tyrosine phosphatase 1B (PTP1B), and nuclear deubiquitinating enzyme (DUB), Uchl5. Our findings show a novel epigenetic regulatory mechanism of adipocyte hypertrophy by Cav-2 at the nuclear periphery.

Keywords: C/EBPα; Caveolin-2; PPARγ; PTP1B; Uchl5; adipocyte hypertrophy; lamin A/C; obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / metabolism
  • Adipogenesis / genetics
  • Animals
  • CCAAT-Enhancer-Binding Protein-alpha / metabolism
  • Caveolin 2 / genetics
  • Caveolin 2 / metabolism
  • Cell Differentiation
  • Humans
  • Hypertrophy / metabolism
  • Lamin Type A* / metabolism
  • Mice
  • Nuclear Lamina / metabolism
  • PPAR gamma* / genetics
  • PPAR gamma* / metabolism

Substances

  • PPAR gamma
  • Lamin Type A
  • Caveolin 2
  • CCAAT-Enhancer-Binding Protein-alpha